adhesive capsulitis
Conditions
Interventions
control group:Single rotator cuff injection: 40mg of triamcinolone acetonide+10ml of 0.4% ropivacaine mixture, administered under ultrasound guidance into the rotator cuff.
Observers:Combination of rotator cuff injection and suprascapular nerve block: 5ml of a mixture of 20mg of triamcinolone acetonide and 0.4% ropivacaine, followed by ultrasound-guided suprascapular ner
A mixture of 40mg of triamcinolone acetonide and 10ml of 0.4% ropivacaine was injected into the rotator cuff space under ultrasound guidance.
Sponsors
Baoqing County People's Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age between 30 and 70 years old, meeting the diagnostic criteria for adhesive shoulder joint capsule inflammation; (2) The active and passive range of motion of the glenohumeral joint in at least two directions (abduction, flexion, external rotation, internal rotation) is limited to>30 °. (3) Course of illness=4 points. (4) Willing to accept the treatment plan of this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Secondary ACS caused by trauma or surgery, osteoarthritis, tumors, local infections, etc. (2) Received shoulder corticosteroid injection therapy within 3 months. (3) Confirmed by imaging examination, such as rotator cuff tear, acromion impingement syndrome, or calcified tendinitis; (4) Uncontrolled diabetes (HbA1c>7%), with coagulation dysfunction;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analog scale,VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder Pain and Disability Index,SPADI ;Passive range of motion of shoulder joint; | — |
Countries
China
Contacts
Public ContactYanli Li
Baoqing County People's Hospital
Outcome results
None listed